President Trump Set To Announce Nationwide Medicaid Drug Pricing Initiative
President Donald Trump is set to announce that all 50 U.S. states will participate in a Medicaid program designed to lower drug prices by matching them to rates paid in certain other countries.
Wilkes Barre Scranton Hazleton, PA, September 18, 2026 —
The White House is preparing to announce a significant initiative aimed at reducing prescription drug costs for Medicaid recipients nationwide. According to the trend summary, President Donald Trump is expected to reveal that all 50 United States will participate in a new program.
This program is designed to specifically target and lower drug prices within the Medicaid system. The mechanism for achieving these lower prices involves benchmarking them against rates paid for the same medications in a selection of other countries. The full details of which countries will be used for comparison and the precise methodology for matching rates were not specified in the summary.
The initiative signifies a broad, federal-level effort to influence pharmaceutical pricing. The participation of all 50 states suggests a comprehensive approach that seeks to standardize drug cost reduction strategies across the country through the Medicaid program. Further details regarding the implementation timeline, specific drug categories, and projected savings are anticipated following the official announcement.
Story summarized from the original created by FATIMA HUSSEIN, Associated Press on www.2822news.com, see more information here.
Media gallery
